期刊
NANOMATERIALS
卷 10, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/nano10101919
关键词
hadron therapy; magnetic nanoparticles; hyperthermia; nanomaterials; magnetic fluid hyperthermia; pancreatic cancer
类别
资金
- INFN HADROCOMBI project
- INFN HADROMAG project
- COST Action (RADIOMAG) [TD1402]
- COST Action EURELAX (EU) [CA15209]
A combination of carbon ions/photons irradiation and hyperthermia as a novel therapeutic approach for the in-vitro treatment of pancreatic cancer BxPC3 cells is presented. The radiation doses used are 0-2 Gy for carbon ions and 0-7 Gy for 6 MV photons. Hyperthermia is realized via a standard heating bath, assisted by magnetic fluid hyperthermia (MFH) that utilizes magnetic nanoparticles (MNPs) exposed to an alternating magnetic field of amplitude 19.5 mTesla and frequency 109.8 kHz. Starting from 37 degrees C, the temperature is gradually increased and the sample is kept at 42 degrees C for 30 min. For MFH, MNPs with a mean diameter of 19 nm and specific absorption rate of 110 +/- 30 W/g(Fe3)o(4) coated with a biocompatible ligand to ensure stability in physiological media are used. Irradiation diminishes the clonogenic survival at an extent that depends on the radiation type, and its decrease is amplified both by the MNPs cellular uptake and the hyperthermia protocol. Significant increases in DNA double-strand breaks at 6 h are observed in samples exposed to MNP uptake, treated with 0.75 Gy carbon-ion irradiation and hyperthermia. The proposed experimental protocol, based on the combination of hadron irradiation and hyperthermia, represents a first step towards an innovative clinical option for pancreatic cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据